an open-label, randomised, phase 3 trial. Lancet Oncol. 2021 Oct;22(10):1378-1390. doi: 10.1016/S1470-2045(21)00428-9. Epub2021 Sep 13. PMID: 34529931. Nieuwenhuizen S, Dijkstra M, Puijk R, Timmer F, Nota I, Opperman J, van den Bemd B, Geboers B, Ruarus A, Schouten E, de Vries J, Scheffer H, van Geel A, van Waesberghe J, Swijnenburg R, Versteeg K, Lissenberg-Witte B, van den Tol M, Haasbeek C, Meijerink M. Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE Registry. Cancers (Basel). 2021 Aug 26;13(17):4303. doi: 10.3390/cancers13174303. PMID: 34503113. Piccart M, van ‘t Veer LJ, Poncet C, Lopes Cardozo JMN, Delaloge S, Pierga J, Vuylsteke P, Brain E, Vrijaldenhoven S, Neijenhuis PA, Causeret S, Smilde TJ, Viale G, Glas AM, Delorenzi M, Sotiriou C, Rubio IT, Kümmel S, Zoppoli G, Thompson AM, Matos E, Zaman K, Hilbers F, Fumagalli D, Ravdin P, Knox S, Tryfonidis K, Peric A, Meulemans B, Bogaerts J, Cardoso F, Rutgers EJT. 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age. Lancet Oncol. 2021 Apr;22(4):476488. doi: 10.1016/S1470-2045(21)00007-3. Epub 2021Mar 12. PMID: 33721561. Posthuma HLA, Zijlstra JM, Visser O, Kersten MJosé, Lugtenburg PJ, Dinmohamed AG. Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands. Blood Cancer J. 2021 May 11;11(5):87. doi: 10.1038/ s41408-021-00482-8. PMID: 33976110. Qaderi S, van der Heijden J, Verhoeven R, de Wilt J, Custers J. Trajectories of health-related quality of life and psychological distress in patients with colorectal cancer: A population-based study. Eur J Cancer. 2021 Oct 16;158:144-155. doi: 10.1016/j. ejca.2021.08.050. PMID: 34666216. Rolvink J, Gerards A, Kater A, Swart E, Becker M. The effect of a Clinical Decision Support System on the frequency of dose adjustments of anticancer drugs in case of renal or hepatic dysfunction. J Oncol Pharm Pract. 2021 Jun 10:10781552211019453. doi: 10.1177/10781552211019453. PMID: 34111993. Schouten R, Vessies D, Bosch L, Barlo N, van Lindert A, Cillessen S, van den Broek D, van den Heuvel M, Monkhorst K. Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced NonSmall-Cell Lung Cancer. JCO Precis Oncol. 2021 Jul 9;5:PO.20.00450. doi: 10.1200/PO.20.00450. eCollection2021 Jul. PMID: 34632253. Smilde B, Louwerenburg A, van Santen M, Hendriks M. Leptomeningeal Metastases From Colorectal Signet-Ring Cell Cancer: A Case Report and Literature Review. Clin Colorectal Cancer. 2021 Nov 28:S1533-0028(21)00126-2. doi:10.1016/j.clcc.2021.11.007. PMID: 34953675. Ten Berge M, Beck N, Steup W, Verhagen A, van Brakel T, Schreurs W, Wouters M. Textbook outcome as a composite outcome measure in non-small-cell lung cancer surgery. Eur J Cardiothorac Surg. 2021 Jan 4;59(1):92-99. doi: 10.1093/ejcts/ezaa265. PMID: 32728711. van den Broek J, Kol S, Doodeman J, Schreurs W, van Geel A. Indeterminate Liver Lesions in Patients With Early Stage Rectal Cancer: Can They Be Ignored? Pract Radiat Oncol. 2021 NovDec;11(6):502-509. doi: 10.1016/j.prro.2021.07.002.Epub 2021 Jul 14. PMID: 34273596. van den Broek JJ, van Gestel T, Kol SQ, van Geel AM, Geenen RWF, Schreurs WH. Dealing with indeterminate pulmonary nodules in colorectal cancer patients; a systematic review. Eur J Surg Oncol. 2021 Nov;47(11):2749-2756. doi: 10.1016/j.ejso.2021.05.043. Epub2021 Jun 6. PMID: 34119380. van der Hout A, Holtmaat K, Jansen F, Lissenberg-Witte B, van Uden-Kraan C, Nieuwenhuijzen G, Hardillo J, Baatenburg de Jong R, Tiren-Verbeet N, Sommeijer D, de Heer K, Schaar C, Sedee R, Bosscha K, van den Brekel M, Petersen J, Westerman M, Honings J, Takes R, Houtenbos I, van den Broek W, de Bree R, Jansen P, Eerenstein S, Leemans C, Zijlstra J, Cuijpers P, van de Poll-Franse L, Verdonck-de Leeuw I. The eHealth self-management application ‘Oncokompas’ that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most? Acta Oncol. 2021 Apr;60(4):403-411. doi: 10.1080/0284186X.2020.1851764. Epub 2020Dec 21. PMID: 33345659. van der Hout A, Jansen F, van Uden-Kraan C, Coupé V, Holtmaat K, Nieuwenhuijzen G, Hardillo J, de Jong R, Tiren-Verbeet N, Sommeijer D, de Heer K, Schaar C, Sedee R, Bosscha K, van den Brekel M, Petersen J, Westerman M, Honings J, Takes R, Houtenbos I, van den Broek W, de Bree R, Jansen P, Eerenstein S, Leemans C, Zijlstra J, Cuijpers P, van de Poll-Franse L, Verdonck-de Leeuw I. Cost-utility of an eHealth application ‘Oncokompas’ that supports cancer survivors in self-management: results of a randomised controlled trial. J Cancer Surviv. 2021 Feb;15(1):77-86. doi: 10.1007/ s11764-020-00912-9. Epub 2020Jul 12. PMID: 32656739. van der Hout A, van Uden-Kraan C, Holtmaat K, Jansen F, Lissenberg-Witte B, Nieuwenhuijzen G, Hardillo J, Baatenburg de Jong R, Tiren-Verbeet N, Sommeijer D, de Heer K, Schaar C, Sedee R, Bosscha K, van den Brekel M, Petersen J, Westerman M, Honings J, Takes R, Houtenbos I, van den Broek W, de Bree R, Jansen P, Eerenstein S, Leemans C, Zijlstra J, Cuijpers P, van de Poll-Franse L, Verdonck-de Leeuw I. Reasons for not reaching or using webbased self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial. Internet Interv. 2021 Jul 15;25:100429. doi: 10.1016/j.invent.2021.100429.eCollection 2021 Sep. PMID: 34401388. van der Kruijssen DEW, Elias SG, Vink GR, van Rooijen KL, ‘t Lam-Boer J, Mol L, Punt CJA, de Wilt JHW, Koopman M. SixtyDay Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial. JAMA Surg. 2021 Dec 1;156(12):1093-1101. doi: 10.1001/ jamasurg.2021.4992. PMID: 34613339. van der Vorst M, Toffoli E, Beusink M, van Linde M, van Voorthuizen T, Brouwer S, van Zweeden A, Vrijaldenhoven S, Berends J, Berkhof J, Verheul H. Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial. Oncologist. 2021 Jan;26(1):e173-e181. doi: 10.1634/theoncologist.2020-0305. Epub2020 Aug 21. PMID: 32735029. van Gelder M, Tournilhac O, Te Raa D, Visser H. Front-line chemoimmunotherapy is not inferior to ibrutinib in CLL. Ann Oncol. 2021 Nov;32(11):1442-1443. doi: 10.1016/j.annonc.2021.08.1990. Epub 2021Aug 21. PMID: 34428511. Wetenschappelijke publicaties 2021 | 96
97 Online Touch Home